133 related articles for article (PubMed ID: 24606449)
21. Genetic impact on prostate anatomical variability during ageing: role of CYP17, SRD5A2 and androgen receptor genes polymorphisms.
Larré S; Hamadeh H; Azzouzi AR; Vallancien G; Cochand-Priollet B; Cancel-Tassin G; Cussenot O
BJU Int; 2007 Sep; 100(3):679-84. PubMed ID: 17669147
[TBL] [Abstract][Full Text] [Related]
22. [Relationship between vitamin D receptor gene Fok I polymorphisms and benign prostatic hyperplasia complicated by histological prostatitis].
Ruan L; Zhong WD; Li ZM; Hua X
Zhonghua Nan Ke Xue; 2011 Oct; 17(10):880-3. PubMed ID: 22049788
[TBL] [Abstract][Full Text] [Related]
23. Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population.
Malecki MT; Frey J; Moczulski D; Klupa T; Kozek E; Sieradzki J
Exp Clin Endocrinol Diabetes; 2003 Dec; 111(8):505-9. PubMed ID: 14714273
[TBL] [Abstract][Full Text] [Related]
24. Association of genetic variants of the vitamin D receptor (VDR) gene (Fok-I, Taq-I and Bsm-I) with susceptibility of benign prostatic hyperplasia in a North Indian population.
Manchanda PK; Konwar R; Nayak VL; Singh V; Bid HK
Asian Pac J Cancer Prev; 2010; 11(4):1005-8. PubMed ID: 21133615
[TBL] [Abstract][Full Text] [Related]
25. The association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in men.
Allen NE; Forrest MS; Key TJ
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):185-9. PubMed ID: 11303586
[TBL] [Abstract][Full Text] [Related]
26. Impact of constitutional genetic variation in androgen/oestrogen-regulating genes on age-related changes in human prostate.
Azzouzi AR; Cochand-Priollet B; Mangin P; Fournier G; Berthon P; Latil A; Cussenot O
Eur J Endocrinol; 2002 Oct; 147(4):479-84. PubMed ID: 12370109
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia.
Tayeb MT; Clark C; Haites NE; Sharp L; Murray GI; McLeod HL
Saudi Med J; 2004 Apr; 25(4):447-51. PubMed ID: 15083213
[TBL] [Abstract][Full Text] [Related]
28. Polymorphism of the SRD5A2 gene and the risk of prostate cancer.
Dušenka R; Tomaškin R; Kliment J; Dobrota D; Dušenková S; Vilčková M; Sivoňová MK
Mol Med Rep; 2014 Dec; 10(6):3151-6. PubMed ID: 25310105
[TBL] [Abstract][Full Text] [Related]
29. VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non-Hispanic White and Hispanic White men.
Torkko KC; van Bokhoven A; Mai P; Beuten J; Balic I; Byers TE; Hokanson JE; Norris JM; Barón AE; Lucia MS; Thompson IM; Leach RJ
Clin Cancer Res; 2008 May; 14(10):3223-9. PubMed ID: 18483391
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D Receptor Gene BSMI, FOKI, APAI, and TAQI Polymorphisms and the Risk of Atopic Dermatitis.
Kılıç S; Sılan F; Hız MM; Işık S; Ögretmen Z; Özdemir Ö
J Investig Allergol Clin Immunol; 2016; 26(2):106-10. PubMed ID: 27164626
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D receptor gene polymorphisms in children with kidney stone disease.
Subaşı B; Gökçe İ; Delil K; Alpay H
Turk J Pediatr; 2017; 59(4):404-409. PubMed ID: 29624220
[TBL] [Abstract][Full Text] [Related]
32. Role of hormonal genes and risk of prostate cancer: gene-gene interactions in a North Indian population.
Sobti RC; Gupta L; Singh SK; Seth A; Kaur P; Thakur H
Cancer Genet Cytogenet; 2008 Sep; 185(2):78-85. PubMed ID: 18722876
[TBL] [Abstract][Full Text] [Related]
33. CYP17 polymorphisms in relation to risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China.
Madigan MP; Gao YT; Deng J; Pfeiffer RM; Chang BL; Zheng S; Meyers DA; Stanczyk FZ; Xu J; Hsing AW
Int J Cancer; 2003 Nov; 107(2):271-5. PubMed ID: 12949806
[TBL] [Abstract][Full Text] [Related]
34. Associations of
Zhang LL; Song Y; He LL; Chen GQ; Fu JC; Liu L; Xi B; Wang L
Int J Clin Exp Pathol; 2017; 10(8):8660-8676. PubMed ID: 31966724
[TBL] [Abstract][Full Text] [Related]
35. Association of polymorphisms in the vitamin D receptor gene and serum 25-hydroxyvitamin D levels in children with autism spectrum disorder.
Coşkun S; Şimşek Ş; Camkurt MA; Çim A; Çelik SB
Gene; 2016 Aug; 588(2):109-14. PubMed ID: 27155524
[TBL] [Abstract][Full Text] [Related]
36. Glutathione S-transferase gene variants and risk of benign prostate hyperplasia in a North Indian population.
Konwar R; Manchanda PK; Chaudhary P; Nayak VL; Singh V; Bid HK
Asian Pac J Cancer Prev; 2010; 11(2):365-70. PubMed ID: 20843117
[TBL] [Abstract][Full Text] [Related]
37. CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia.
Tayeb MT; Clark C; Haites NE; Sharp L; Murray GI; McLeod HL
Br J Cancer; 2003 Mar; 88(6):928-32. PubMed ID: 12644831
[TBL] [Abstract][Full Text] [Related]
38. CYP17, SRD5A2, CYP1B1, and CYP2D6 gene polymorphisms with prostate cancer risk in North Indian population.
Sobti RC; Onsory K; Al-Badran AI; Kaur P; Watanabe M; Krishan A; Mohan H
DNA Cell Biol; 2006 May; 25(5):287-94. PubMed ID: 16716118
[TBL] [Abstract][Full Text] [Related]
39. [Genetic determinants of anatomical variants of the prostate].
Hamadeh H; Larré S; Azzouzi AR; Cancel-Tassin G; Vallancien G; Cochand-Priollet B; Cussenot O
Prog Urol; 2008 Apr; 18(4):214-22. PubMed ID: 18501301
[TBL] [Abstract][Full Text] [Related]
40. Association of vitamin D receptor gene polymorphisms with diabetic dyslipidemia in the elderly male population in North China.
Xia Z; Hu Y; Han Z; Gao Y; Bai J; He Y; Zhao H; Zhang H
Clin Interv Aging; 2017; 12():1673-1679. PubMed ID: 29066872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
